Navigation Links
Intravenous Delivery of Clot-busting Drug Still Best Intervention for Ischemic Stroke

Intravenous delivery of an approved clot-busting drug remains the most beneficial proven intervention for ischemic stroke, according to American Heart Association.//

The Guidelines for the Early Management of Adults with Ischemic Stroke also indicate that new options – such as intra-arterial administration of clot-busting drugs and mechanical removal of blood clots – show promise.

The guidelines focus on the crucial first hours from the time an ischemic stroke occurs through emergency evaluation and treatment in a hospital. Ischemic strokes, the most common type of stroke, are caused by a clot that blocks blood flow in an artery to the brain.

The panel emphasized the importance of public education on the symptoms of stroke, which include:

? Sudden numbness or weakness of the face, arm or leg, especially on one side of the body

? Sudden confusion, trouble speaking or understanding

? Sudden trouble seeing in one or both eyes

? Sudden trouble walking, dizziness, loss of balance or coordination

? Sudden, severe headache with no known cause

Patients or observers should call 9-1-1 when stroke symptoms first develop.

"We are pushing for the fastest possible treatment because 'time is brain.' For every minute that goes by, the likelihood of a poorer outcome increases," said Harold P. Adams, Jr., M.D., chairman of the writing group.

Intravenous delivery of the clot-busting drug tissue plasminogen activator (tPA) is only approved to be used within three hours of symptom onset.

The panel said other techniques – mechanical devices and intra-arterial administration (IA) of tPA – are becoming more widely available and should be considered for patients with moderate-to-severe strokes who arrive at the hospital too late to receive intravenous tPA. However, information on these techniques is limited and more research is needed.

The n ew guidelines suggest emergency medical personnel perform a quick stroke assessment, draw blood and alert the hospital that a patient with a suspected stroke is coming. Patients should also be transported to the nearest "appropriate" hospital for emergency stroke care even if that means bypassing the closest facility or calling for air evacuation.

"Appropriate" facilities are those with the expertise and resources to provide modern emergency stroke care. Regional plans for paramedics to bypass institutions that do not have emergency stroke care should be developed, according to the guidelines.

The updated guidelines are an extensive revision of those issued in 2003 and 2005. Among the new or revised recommendations:

Hospitals should develop emergency stroke protocols so patients can be assessed and treated within 60 minutes of arrival in an emergency treatment center.

More medical centers should seek certification as primary or comprehensive stroke centers from the Joint Commission on Accreditation of Healthcare Organizations.

Patients should receive early and carefully chosen treatments for abnormal blood pressure, fever or abnormal blood sugar levels, which can negatively affect stroke outcome.

Although clot-dissolving drugs other than tPA are being tested, none has been established as effective and they should only be given as part of a clinical trial. For the first time, the association has included comments about palliative or comfort care of a patient with a devastating brain injury.

"We included this in the document so that physicians may recognize that they can take measures to not prolong suffering or dying in a patient whose extensive brain injury will result in a fatal outcome," Adams said.

Source-Eurekalert
SR/V
'"/>




Related medicine news :

1. Painkilling Patch As Effective As Intravenous Delivery Systems
2. Intravenous Vitamin C (Ascorbate) for Cancer Treatment
3. Oral use of ZYVOX (Linezolid) is better to Intravenous Vancomycin use for Skin Infections
4. Intravenous Iron treats anemia of pregnancy faster
5. Advance in Program for Development of Non-Intravenous Therapy for Hemophilia
6. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
7. Link between C-section Delivery and Stillbirth
8. Painkilling Patch As Effective As Intravenous Delivery Systems
9. The Effects Of Delaying A Delivery Questioned
10. Drug Delivery Made More Patient Friendly And Safe
11. Medical Gadgets To Monitor Drug Delivery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, ... and organizations with the tools and information to lower the costs, and increase ... the cost of providing employee healthcare benefits by as much as 22%:, + ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... , ... February 06, 2016 ... ... 303-368-6225 , MEDIA ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE ... perioperative nurses in the world with an estimated 5000 perioperative nurses in ...
(Date:2/6/2016)... ... February 06, 2016 , ... US Sports Camps is ... (YUCC) . This event brings together top non-profit leaders, ultimate organizations, and coaches from ... Ultimate”. Valerio Iani, Bay Area Disc Program Director of Youth and Education, describes this ...
(Date:2/6/2016)... Viejo, CA (PRWEB) , ... February 06, 2016 , ... ... quickly and easily add warm color grades to their footage. A LUT is a ... every pixel's color to the corresponding color indicated by the table. By manipulating each ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  Patients in Alabama ... focused ultrasound (HIFU) therapy no longer have to travel out ... its partnership with Urology Centers of Alabama to ... FDA-cleared procedure for qualifying patients. Alabama ... in the treatment of prostate cancer using many different modalities. ...
(Date:2/5/2016)... 5, 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ... CEO, will be presenting at Source Capital Group,s 2016 Disruptive ... at 2:15 p.m. ET on Wednesday, February 10, ... discussion taking place at 3:15 p.m. ET. http://www.aethlonmedical.com ... hour after the conclusion of the live event. The panel ...
(Date:2/5/2016)... 5, 2016 Dehaier Medical Systems Ltd. ... "Company"), which develops, markets and sells medical devices ... China and international markets, today announced ... to concentrate the Company,s resources to develop its ... and to focus more on its major businesses. ...
Breaking Medicine Technology: